サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：世界の羊膜製品市場調査レポート－業界分析、規模、シェア、成長、動向、予測（2020年～2027年）
市場調査レポート
商品コード
1032971

世界の羊膜製品市場調査レポート－業界分析、規模、シェア、成長、動向、予測（2020年～2027年）

Global Amniotic Products Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2020 to 2027
出版日: | 発行: Value Market Research | ページ情報: 英文 321 Pages | 納期: 即日から翌営業日
AI翻訳ツール 提供対象
ご購入後の翻訳ツール提供について

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=137.14円
世界の羊膜製品市場調査レポート－業界分析、規模、シェア、成長、動向、予測（2020年～2027年）
出版日: 2021年10月01日
発行: Value Market Research
ページ情報: 英文 321 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の羊膜製品市場規模は、2021年から2027年の予測期間内に大幅な成長を遂げると予測されています。

当レポートでは、世界の羊膜製品市場について調査しており、業界分析、バリューチェーン分析、市場分析、企業プロファイルなど、包括的な情報を提供しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 羊膜製品－業界分析

  • イントロダクション－市場力学
  • 市場の成長要因
  • 市場の抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
  • 潜在バイヤーリスト
  • マーケティングチャネル

第5章 COVID-19アウトブレイクの影響分析

  • COVID-19アウトブレイクの影響分析
  • COVID-19の影響分析：生産別・輸入別・輸出別・需要別
  • 市場：プレCOVID-19 vs ポストCOVID-19
  • コロナウイルス（COVID-19）の流行の推定される影響
  • COVID-19：ミクロおよびマクロ因子分析

第6章 世界の羊膜製品市場分析：タイプ別

  • 概要：タイプ別
  • 過去および予測データ
  • 分析：タイプ別
  • 羊膜市場：地域別
  • 凍結保存羊膜市場：地域別
  • 脱水羊膜市場：地域別
  • 羊膜懸濁液市場：地域別

第7章 世界の羊膜製品市場分析：アプリケーション別

  • 概要：アプリケーション別
  • 過去および予測データ
  • 分析：アプリケーション別
  • 創傷ケア市場：地域別
  • 整形外科市場：地域別
  • 眼科市場：地域別
  • その他のアプリケーション市場：地域別

第8章 世界の羊膜製品市場分析：エンドユーザー別

  • 概要：エンドユーザー別
  • 過去および予測データ
  • 分析：エンドユーザー別
  • 病院およびASC市場：地域別
  • その他のエンドユーザー市場：地域別

第9章 世界の羊膜製品市場分析：地域別

  • 地域の見通し
  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東とアフリカ

第10章 羊膜製品企業の競合情勢

  • 羊膜製品市場競争
  • パートナーシップ・協業・契約
  • 合併と買収
  • 新製品の発売
  • その他の展開

第11章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • MiMedx（米国）
  • Smith &Nephew（英国）
  • Organogenesis Inc.（米国）
  • Integra LifeSciences（米国）
  • Stryker（米国）
  • Applied Biologics（米国）
  • Celularity, Inc.（米国）
  • Katena Products, Inc.（米国）
  • Lucina BioSciences（米国）
  • Next Biosciences（南アフリカ）
  • Skye Biologics Holdings, LLC（米国）
  • Surgenex（米国）
  • TissueTech, Inc.（米国）
  • Ventris Medical, LLC（米国）
  • StimLabs LLC（米国）
  • VIVEX Biologics, Inc.（米国）
  • LifeCell International Pvt. Ltd.（インド）
  • NuVision Biotherapies Ltd.（英国）

注－企業のプロファイリングでは、財務情報と最近の展開は入手情報に依存しています。民間企業の場合、これらがカバーされない場合があります。

図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Type (USD MN)
  • Amniotic Membranes Market by Geography (USD MN)
  • Cryopreserved Amniotic Membranes Market by Geography (USD MN)
  • Dehydrated Amniotic Membranes Market by Geography (USD MN)
  • Amniotic Suspensions Market by Geography (USD MN)
  • Analysis Market by Application (USD MN)
  • Wound Care Market by Geography (USD MN)
  • Orthopedics Market by Geography (USD MN)
  • Ophthalmology Market by Geography (USD MN)
  • Other Applications Market by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Hospitals & ASCs Market by Geography (USD MN)
  • Other End Users Market by Geography (USD MN)
  • Global Amniotic Products Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Amniotic Products Report
  • Market Research Process
  • Market Research Methodology
  • Global Amniotic Products Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Amniotic Membranes Market by Geography (USD MN)
  • Cryopreserved Amniotic Membranes Market by Geography (USD MN)
  • Dehydrated Amniotic Membranes Market by Geography (USD MN)
  • Amniotic Suspensions Market by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Wound Care Market by Geography (USD MN)
  • Orthopedics Market by Geography (USD MN)
  • Ophthalmology Market by Geography (USD MN)
  • Other Applications Market by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Hospitals & ASCs Market by Geography (USD MN)
  • Other End Users Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11216275

Value Market Research's latest report on the Global Amniotic Products Market identified a significant growth in the industry over the last few years and anticipates it to grow considerably within the forecast period of 2021-2027.

The global amniotic products market report provides a complete evaluation of the market for the forecast period. The report consists of various segments as well as an analysis of the factors playing a significant role in the market. The factors include the drivers, restraints, challenges and opportunities and the impact of these factors on the market has been provided in the report. The drivers and restraints are classified as intrinsic factors while the opportunities and challenges are classified as extrinsic factors of the market. The global amniotic products market study provides an insight on the developments of the market in terms of revenue throughout the specified period.

This report provides a complete analysis for the global amniotic products market. An in-depth secondary research, primary interviews and in-house expert reviews are responsible for providing the market estimates for the global amniotic products market. These market estimates have been put together by studying the impact of different social, political and economic factors along with the current market dynamics that are affecting the global amniotic products market growth.

The report begins with the market overview, followed by a crisp executive summary. The Porter's Five Forces analysis covered in this study will assist in understanding the five forces namely buyers bargaining power, suppliers bargaining power, threat of new entrants, the threat of substitutes and the degree of competition in the global amniotic products market. It also helps to explain the various participants such as system integrators, intermediaries and end users within the market. The report by Value Market Research also focuses on the competitive landscape of the global amniotic products market.

The market analysis involves a section exclusively to list the major players of the global amniotic products market wherein our analysts provide an insight into the financial statements of all the key players along with its key development product. The company profile section in the report also provides a business overview and financial information. The companies provided in this section can be customized as per the client's requirement.

The Amniotic Products Market Report Segments the market as below:

By Type

  • Amniotic Membranes
  • Cryopreserved Amniotic Membranes
  • Dehydrated Amniotic Membranes
  • Amniotic Suspensions

By Application

  • Wound Care
  • Orthopedics
  • Ophthalmology
  • Other Applications

By End User

  • Hospitals & ASCs
  • Other End Users

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . AMNIOTIC PRODUCTS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Type
    • 3.7.2 By Application
    • 3.7.3 By End User
    • 3.7.4 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL AMNIOTIC PRODUCTS MARKET ANALYSIS BY TYPE

  • 6.1 Overview by Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type
  • 6.4 Amniotic Membranes Market by Regions
  • 6.5 Cryopreserved Amniotic Membranes Market by Regions
  • 6.6 Dehydrated Amniotic Membranes Market by Regions
  • 6.7 Amniotic Suspensions Market by Regions

7 . GLOBAL AMNIOTIC PRODUCTS MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 Wound Care Market by Regions
  • 7.5 Orthopedics Market by Regions
  • 7.6 Ophthalmology Market by Regions
  • 7.7 Other Applications Market by Regions

8 . GLOBAL AMNIOTIC PRODUCTS MARKET ANALYSIS BY END USER

  • 8.1 Overview by End User
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End User
  • 8.4 Hospitals & ASCs Market by Regions
  • 8.5 Other End Users Market by Regions

9 . GLOBAL AMNIOTIC PRODUCTS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America
    • 9.3.1. Overview, Historic and Forecast Data
    • 9.3.2. North America By Segment
    • 9.3.3. North America By Country
    • 9.3.4. United State
    • 9.3.5. Canada
    • 9.3.6. Mexico
  • 9.4. Europe
    • 9.4.1. Overview, Historic and Forecast Data
    • 9.4.2. Europe by Segment
    • 9.4.3. Europe by Country
    • 9.4.4. United Kingdom
    • 9.4.5. France
    • 9.4.6. Germany
    • 9.4.7. Italy
    • 9.4.8. Russia
    • 9.4.9. Rest Of Europe
  • 9.5. Asia Pacific
    • 9.5.1. Overview, Historic and Forecast Data
    • 9.5.2. Asia Pacific by Segment
    • 9.5.3. Asia Pacific by Country
    • 9.5.4. China
    • 9.5.5. India
    • 9.5.6. Japan
    • 9.5.7. South Korea
    • 9.5.8. Australia
    • 9.5.9. Rest Of Asia Pacific
  • 9.6. Latin America
    • 9.6.1. Overview, Historic and Forecast Data
    • 9.6.2. Latin America by Segment
    • 9.6.3. Latin America by Country
    • 9.6.4. Brazil
    • 9.6.5. Argentina
    • 9.6.6. Peru
    • 9.6.7. Chile
    • 9.6.8. Rest of Latin America
  • 9.7. Middle East & Africa
    • 9.7.1. Overview, Historic and Forecast Data
    • 9.7.2. Middle East & Africa by Segment
    • 9.7.3. Middle East & Africa by Country
    • 9.7.4. Saudi Arabia
    • 9.7.5. UAE
    • 9.7.6. Israel
    • 9.7.7. South Africa
    • 9.7.8. Rest Of Middle East And Africa

10 . COMPETITIVE LANDSCAPE OF THE AMNIOTIC PRODUCTS COMPANIES

  • 10.1. Amniotic Products Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF AMNIOTIC PRODUCTS INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. MiMedx (US)
    • 11.3.1. Company Overview
    • 11.3.2. Financials
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Smith & Nephew (UK)
    • 11.4.1. Company Overview
    • 11.4.2. Financials
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Organogenesis Inc. (US)
    • 11.5.1. Company Overview
    • 11.5.2. Financials
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Integra LifeSciences (US)
    • 11.6.1. Company Overview
    • 11.6.2. Financials
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Stryker (US)
    • 11.7.1. Company Overview
    • 11.7.2. Financials
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Applied Biologics (US)
    • 11.8.1. Company Overview
    • 11.8.2. Financials
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Celularity, Inc. (US)
    • 11.9.1. Company Overview
    • 11.9.2. Financials
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Katena Products, Inc. (US)
    • 11.10.1. Company Overview
    • 11.10.2. Financials
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Lucina BioSciences (US)
    • 11.11.1. Company Overview
    • 11.11.2. Financials
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Next Biosciences (South Africa)
    • 11.12.1. Company Overview
    • 11.12.2. Financials
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. Skye Biologics Holdings, LLC (US)
    • 11.13.1. Company Overview
    • 11.13.2. Financials
    • 11.13.3. Products
    • 11.13.4. Recent Developments
  • 11.14. Surgenex (US)
    • 11.14.1. Company Overview
    • 11.14.2. Financials
    • 11.14.3. Products
    • 11.14.4. Recent Developments
  • 11.15. TissueTech, Inc. (US)
    • 11.15.1. Company Overview
    • 11.15.2. Financials
    • 11.15.3. Products
    • 11.15.4. Recent Developments
  • 11.16. Ventris Medical, LLC (US)
    • 11.16.1. Company Overview
    • 11.16.2. Financials
    • 11.16.3. Products
    • 11.16.4. Recent Developments
  • 11.17. StimLabs LLC (US)
    • 11.17.1. Company Overview
    • 11.17.2. Financials
    • 11.17.3. Products
    • 11.17.4. Recent Developments
  • 11.18. VIVEX Biologics, Inc. (US)
    • 11.18.1. Company Overview
    • 11.18.2. Financials
    • 11.18.3. Products
    • 11.18.4. Recent Developments
  • 11.19. LifeCell International Pvt. Ltd. (India)
    • 11.19.1. Company Overview
    • 11.19.2. Financials
    • 11.19.3. Products
    • 11.19.4. Recent Developments
  • 11.20. NuVision Biotherapies Ltd. (UK)
    • 11.20.1. Company Overview
    • 11.20.2. Financials
    • 11.20.3. Products
    • 11.20.4. Recent Developments
  • 11.20. NuVision Biotherapies Ltd. (UK)
    • 11.20.1. Company Overview
    • 11.20.2. Financials
    • 11.20.3. Products
    • 11.20.4. Recent Developments
  • 11.20. NuVision Biotherapies Ltd. (UK)
    • 11.20.1. Company Overview
    • 11.20.2. Financials
    • 11.20.3. Products
    • 11.20.4. Recent Developments
  • 11.20. NuVision Biotherapies Ltd. (UK)
    • 11.20.1. Company Overview
    • 11.20.2. Financials
    • 11.20.3. Products
    • 11.20.4. Recent Developments
  • 11.20. NuVision Biotherapies Ltd. (UK)
    • 11.20.1. Company Overview
    • 11.20.2. Financials
    • 11.20.3. Products
    • 11.20.4. Recent Developments
  • 11.20. NuVision Biotherapies Ltd. (UK)
    • 11.20.1. Company Overview
    • 11.20.2. Financials
    • 11.20.3. Products
    • 11.20.4. Recent Developments
  • 11.20. NuVision Biotherapies Ltd. (UK)
    • 11.20.1. Company Overview
    • 11.20.2. Financials
    • 11.20.3. Products
    • 11.20.4. Recent Developments
  • 11.20. NuVision Biotherapies Ltd. (UK)
    • 11.20.1. Company Overview
    • 11.20.2. Financials
    • 11.20.3. Products
    • 11.20.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies